Rapamycin Does Not Impede Survival or Induction of Antibody Responses to Primary and Heterosubtypic Influenza Infections in Mice

Impairment of immune defenses can contribute to severe influenza infections. Rapamycin is an immunosuppressive drug often used to prevent transplant rejection and is currently undergoing clinical trials for treating cancers and autoimmune diseases. We investigated whether rapamycin has deleterious e...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Viral Immunol
Huvudupphovsmän: Liepkalns, Justine S., Pandey, Aseem, Hofstetter, Amelia R., Kumar, Amrita, Jones, Enitra N., Cao, Weiping, Liu, Feng, Levine, Min Z., Sambhara, Suryaprakash, Gangappa, Shivaprakash
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5749914/
https://ncbi.nlm.nih.gov/pubmed/27447349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/vim.2016.0056
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk